CH277825A - Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen. - Google Patents

Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen.

Info

Publication number
CH277825A
CH277825A CH277825DA CH277825A CH 277825 A CH277825 A CH 277825A CH 277825D A CH277825D A CH 277825DA CH 277825 A CH277825 A CH 277825A
Authority
CH
Switzerland
Prior art keywords
preparation
solutions containing
injection solutions
levulose
containing levulose
Prior art date
Application number
Other languages
English (en)
Inventor
Coffarom Aktiengesellschaft
Original Assignee
Coffarom Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coffarom Aktiengesellschaft filed Critical Coffarom Aktiengesellschaft
Publication of CH277825A publication Critical patent/CH277825A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C13SUGAR INDUSTRY
    • C13KSACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K11/00Fructose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH277825D 1949-03-02 1949-02-05 Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen. CH277825A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB574149A GB668850A (en) 1949-03-02 1949-03-02 Improved process for producing laevulose-containing solutions for injection purposes

Publications (1)

Publication Number Publication Date
CH277825A true CH277825A (de) 1951-09-15

Family

ID=9801776

Family Applications (1)

Application Number Title Priority Date Filing Date
CH277825D CH277825A (de) 1949-03-02 1949-02-05 Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen.

Country Status (2)

Country Link
CH (1) CH277825A (de)
GB (1) GB668850A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021953A1 (de) * 1979-06-15 1981-01-07 Henri Griffon Stabile wässrige Alloxanlösungen

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990327A (en) * 1960-07-14 1961-06-27 Synergistics Inc Composition and method for treating biliary dyskinesia

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021953A1 (de) * 1979-06-15 1981-01-07 Henri Griffon Stabile wässrige Alloxanlösungen

Also Published As

Publication number Publication date
GB668850A (en) 1952-03-26

Similar Documents

Publication Publication Date Title
CH290905A (de) Verfahren zur Herstellung von Halbzellstoff.
CH282375A (de) Verfahren zur Herstellung von Organohalogensilanen.
CH292033A (de) Verfahren zur Herstellung von Spinndüsen.
CH277825A (de) Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen.
CH279908A (de) Verfahren zur Herstellung von Alkylhalogensilanen.
CH298055A (de) Verfahren zur Herstellung von 1-Phenyl-1-pyridyl-(2')-3-N-pyrolidino-propan-p-amino-salicylat.
CH299374A (de) Verfahren zur Herstellung von Lösungen von Polymerisaten des Akrylnitrils.
AT171709B (de) Verfahren zur Herstellung von Oximen
AT172334B (de) Verfahren zur Herstellung von N-Dialkylaminoalkylphenthiazinen
CH284350A (de) Verfahren zur Herstellung von Spinndüsen.
CH264601A (de) Verfahren zur Herstellung von Hydroxylaminsulfat-Lösungen.
CH295660A (de) Verfahren zur Herstellung von alkylierten Arylmethyl-methylketonen.
CH285128A (de) Verfahren zur Herstellung von Estern.
AT181692B (de) Verfahren zur Herstellung von zur Injektion bestimmten Präparaten
CH296339A (de) Verfahren zur Herstellung von N-(B-Phenyl-äthyl)-äthylenimin.
CH281125A (de) Verfahren zur Herstellung von Thiosemicarbazid.
AT182823B (de) Verfahren zur Herstellung wässeriger, zur Injektion geeigneter Lösungen von Chlortetracyclin
AT171176B (de) Verfahren zur Herstellung von 17α-Methyl-pregnenverbindungen
AT176307B (de) Verfahren zur Herstellung von 20-Keto-pregnanen
AT169834B (de) Verfahren zur Herstellung von Pentaenen
AT178203B (de) Verfahren zur Herstellung von Hartfaserplatten
AT182196B (de) Verfahren zur Herstellung von Injektionslösungen
AT169805B (de) Verfahren zur Herstellung von Polysiloxanen
AT167872B (de) Verfahren zur Herstellung von Injektionslösungen des Chlorhydrates des Methyl-bis-β-Chloräthylamins
AT178163B (de) Verfahren zur Herstellung von Spasmolytika